Interstitial Lung Disease Research Unit Biobank

Recruiting

• Conditions: Sarcoidosis; Interstitial Lung Disease; Pulmonary Fibrosis; Idiopathic Pulmonary Fibrosis; Hypersensitivity Pneumonitis

• Registration Number: NCT05392881
• Lead Sponsor: University of Kansas Medical Center

Brief Summary

Establish a interstitial lung disease (ILD) registry and biorepository to lead towards a further understanding of the disease.

Detailed Description

The University of Kansas ILD and Rare Lung Disease clinic sees hundreds of new patients per year. The investigators would like to leverage this resource to develop an Interstitial Lung Disease Research Unit (ILDRU) repository and database to help develop new methods for early diagnosis, uncover underlying genetic and environmental risk factors, as well as potential treatment targets in the broad range of interstitial lung diseases and rare lung diseases (RLD).

Study Timeline

• Study Start: 2021-08-09
• Study First Submitted: 2022-05-22
• Study First Submitted QC: 2022-05-22
• Study First Posted: 2022-05-26
• Status Verified: 2024-10
• Last Update Submitted: 2024-10-07
• Last Update Posted: 2024-10-10
• Primary Completion: 2031-08-01
• Study Completion: 2032-03-01

Recruitment & Eligibility

• Status: RECRUITING
• Sex: All
• Target Recruitment: 1000

Inclusion Criteria

1. The participant is a patient at TUKHS or has agreed to participate in a study approved by the KUMC Human Research Protection Program (HRPP)
2. The participant is being followed for the presence of autoimmune disease, ILD or other rare lung diseases at TUKHS.
3. The participant is ≥ 18 years of age.
4. The participant has signed an approved consent for this study (living patients only)

Exclusion Criteria

Not provided

Study & Design

• Study Type: OBSERVATIONAL
• Study Design: Not specified

Primary Outcome Measures

Name	Time	Method
Collect clinically obtained data for patients with ILD, RLD and risk for ILD/RLD to support research.	Enrollment to Year 10
Establish a collection of biological samples from patients with ILD, RLD and subjects at risk for ILD.	Enrollment to Year 10
Correlate biological samples with individual longitudinal clinical data.	Enrollment to Year 10
Provide biological samples to researchers performing studies in ILD and RLD.	Enrollment to Year 10
Collect historical data and imaging from deceased patients with ILD.	Enrollment to Year 10

Trial Locations

Locations (1)

The University of Kansas Medical Center; 🇺🇸 Kansas City, Kansas, United States